Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates-Reference-Cited by-同舟云学术

Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates

Published:2019-03-04 Issue:5 Volume:85 Page:865-867
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Leroux Stéphanie¹²^ORCID,Anker Johannes N.¹³,Smits Anne⁴⁵,Pfister Marc¹⁶,Allegaert Karel⁵⁷

Affiliation:

1. Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel University of Basel Basel Switzerland

2. Neonatal Intensive Care Unit University Hospital Rennes Rennes France

3. Division of Clinical Pharmacology Children's National Health System Washington DC USA

4. Neonatal Intensive Care Unit University Hospitals Leuven Leuven Belgium

5. Department of Development and Regeneration KU Leuven Leuven Belgium

6. Certara LP Princeton NJ USA

7. Department of Pediatrics, Division of Neonatology, Erasmus MC Sophia Children's Hospital University Medical Center Rotterdam Rotterdam The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13899

Reference9 articles.

1. External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings

2. Duration of vancomycin treatment for coagulase-negativeStaphylococcussepsis in very low birth weight infants

3. Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration

4. Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections

5. Factors impacting unbound vancomycin concentrations in neonates and young infants

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age-Related Changes in Vancomycin Protein Binding: Is it Time to Take it Seriously?;Therapeutic Drug Monitoring;2024-03-29

2. Performing clinical drug trials in acute and critically ill neonates and children;Essentials of Translational Pediatric Drug Development;2024

3. Real-Life Vancomycin Therapeutic Drug Monitoring in Coagulase-Negative Staphylococcal Bacteremia in Neonatal and Pediatric Intensive Care Unit: Are We Underestimating Augmented Renal Clearance?;Antibiotics;2023-10-26

4. Developmental Pharmacokinetics of Antibiotics Used in Neonatal ICU: Focus on Preterm Infants;Biomedicines;2023-03-17

5. Vancomycin Dosing Regimens based on Monte Carlo Simulation for Treated Gram-positive cocci Infection in neonates: A retrospective observational study;2022-11-16